Sponsors
PressureWire™ X – CoroFlow™ Cardiovascular System
Go beyond the angiogram with PressureWire™ X, together with the CoroFlow™ Cardiovascular System. This one-wire solution offers a complete physiological evaluation, allowing you to assess epicardial disease with FFR & RFR while simultaneously evaluating microvascular function through CFR & IMR. Going one step further, PPG analysis differentiates focal from diffuse coronary disease, providing deeper insights to guide revascularization and treatment options.
HEXACATH is an independent European company founded in 1994 in France which develops, manufactures and distributes innovative devices in interventional cardiology dedicated to treat patients affected with Myocardial Infarction (MI) such as the unique Bio Active Coronary Stent (BAS) TiTAN OPTIMAX dedicated to AMI with coronary lesions and the one and only Microcirculation catheter RAYFLOW dedicated to AMI with non obstructive coronary arteries.
Philips is a leading health technology company focused on improving people’s lives – from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that help provide improved patient experience, better health outcomes, improved staff experience, and lower cost of care. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.
Shockwave Reducer
Treating the pain of refractory angina is now possible, even if your patient’s discomfort is uncontrollable by traditional medical therapies. Shockwave Reducer is an innovative technology designed to provide much-needed relief to patients suffering from the symptoms of refractory angina by creating a permanent, controlled narrowing of the coronary sinus.